Genomic Expression Inc.
Beverly, MA
- UEI
- L9V9R1GLE9Z6
- CAGE
- 5SRD6
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 621511 Medical Laboratories Primary
- 325413 In-Vitro Diagnostic Substance Manufacturing
- 325414 Biological Product (except Diagnostic) Manufacturing
- 334516 Analytical Laboratory Instrument Manufacturing
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- 541990 All Other Professional, Scientific, and Technical Services
- SAM.gov registration date
- Physical address
- 100 Cummings Center #451c, Beverly, MA 01915, USA
- Website
- genomicexpression.com
- Founded
- 2009
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| EO 14042 sbir topic 425 phase i: posture analysis through machine learning (pathml) | National Cancer Institute | $340,334 |
Quick answers
What is Genomic Expression Inc.'s UEI?
Genomic Expression Inc.'s Unique Entity ID (UEI) in SAM.gov is L9V9R1GLE9Z6.
What is Genomic Expression Inc.'s CAGE code?
Genomic Expression Inc.'s CAGE code is 5SRD6.
What is Genomic Expression Inc.'s primary NAICS code?
Genomic Expression Inc.'s primary NAICS code is 621511 (Medical Laboratories).
Where is Genomic Expression Inc. located?
Genomic Expression Inc.'s physical address in SAM.gov is 100 Cummings Center #451c, Beverly, MA 01915, USA.
Is Genomic Expression Inc. registered in SAM.gov?
Yes. Genomic Expression Inc.'s SAM.gov registration is active through April 5, 2027.
What is Genomic Expression Inc.'s most recent federal award?
Genomic Expression Inc.'s most recent federal contract award is EO 14042 sbir topic 425 phase i: posture analysis through machine learning (pathml) (75N91023C00007), from National Cancer Institute, on February 28, 2023.
On GovTribe
See Genomic Expression Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors